Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016

Introduction Under the Global Programme to Eliminate Lymphatic Filariasis (LF), American Samoa conducted seven rounds of mass drug administration (MDA) from 2000–2006. The World Health Organization recommends systematic post-MDA surveillance using Transmission Assessment Surveys (TAS) for epidemiological assessment of recent LF transmission. We compared the effectiveness of two survey designs for post-MDA surveillance: a school-based survey of children aged 6–7 years, and a community-based survey targeting people aged ≥8 years. Methods In 2016, we conducted a systematic school-based TAS in all elementary schools (N = 29) and a cluster survey in 28 villages on the two main islands of American Samoa. We collected information on demographics and risk factors for infection using electronic questionnaires, and recorded geo-locations of schools and households. Blood samples were collected to test for circulating filarial antigen (CFA) using the Alere Filariasis Test Strip. For those who tested positive, we prepared slides for microscopic examination of microfilaria and provided treatment. Descriptive statistics were performed for questionnaire variables. Data were weighted and adjusted to account for sampling design and sex for both surveys, and for age in the community survey. Results The school-based TAS (n = 1143) identified nine antigen-positive children and found an overall adjusted CFA prevalence of 0.7% (95% CI: 0.3–1.8). Of the nine positive children, we identified one microfilariaemic 7-year-old child. The community-based survey (n = 2507, 711 households) identified 102 antigen-positive people, and estimated an overall adjusted CFA prevalence of 6.2% (95% CI: 4.5–8.6). Adjusted village-level prevalence ranged from 0–47.1%. CFA prevalence increased with age and was higher in males. Of 86 antigen-positive community members from whom slides were prepared, 22 (25.6%) were microfilaraemic. School-based TAS had limited sensitivity (range 0–23.8%) and negative predictive value (range 25–83.3%) but had high specificity (range 83.3–100%) and positive predictive value (range 0–100%) for identifying villages with ongoing transmission. Conclusions American Samoa failed the school-based TAS in 2016, and the community-based survey identified higher than expected numbers of antigen-positive people. School-based TAS was logistically simpler and enabled sampling of a larger proportion of the target population, but the results did not provide a good indication of the overall CFA prevalence in older age groups and was not sensitive at identifying foci of ongoing transmission. The community-based survey, although operationally more challenging, identified antigen-positive individuals of all ages, and foci of high antigen prevalence. Both surveys confirmed recrudescence of LF transmission.

[1]  T. Nutman,et al.  Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa , 2018, PLoS neglected tropical diseases.

[2]  P. Graves,et al.  Overview of PacELF—the Pacific Programme for the Elimination of Lymphatic Filariasis , 2017, Tropical Medicine and Health.

[3]  P. Graves,et al.  Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration , 2017, PLoS neglected tropical diseases.

[4]  P. Graves,et al.  Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration , 2017, Tropical Medicine and Health.

[5]  Ryan E Wiegand,et al.  Detecting infection hotspots: Modeling the surveillance challenge for elimination of lymphatic filariasis , 2017, PLoS neglected tropical diseases.

[6]  P. Graves,et al.  Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame , 2016, PLoS neglected tropical diseases.

[7]  Viet Nam SARS-free Global programme to eliminate lymphatic filariasis: progress report, 2015. , 2016, Releve epidemiologique hebdomadaire.

[8]  R. Rao,et al.  A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration , 2015, Parasites & Vectors.

[9]  K. Ramaiah,et al.  Progress and Impact of 13 Years of the Global Programme to Eliminate Lymphatic Filariasis on Reducing the Burden of Filarial Disease , 2014, PLoS neglected tropical diseases.

[10]  J. Miller,et al.  A Comprehensive Assessment of Lymphatic Filariasis in Sri Lanka Six Years after Cessation of Mass Drug Administration , 2014, PLoS neglected tropical diseases.

[11]  R. S. Soares Magalhaes,et al.  Seroprevalence and Spatial Epidemiology of Lymphatic Filariasis in American Samoa after Successful Mass Drug Administration , 2014, PLoS neglected tropical diseases.

[12]  Steven A. Williams,et al.  Molecular Xenomonitoring Using Mosquitoes to Map Lymphatic Filariasis after Mass Drug Administration in American Samoa , 2014, PLoS neglected tropical diseases.

[13]  A. Pavluck,et al.  Electronic Data Capture Tools for Global Health Programs: Evolution of LINKS, an Android-, Web-Based System , 2014, PLoS neglected tropical diseases.

[14]  R. Rao,et al.  Transmission Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A Multicenter Evaluation , 2013, PLoS neglected tropical diseases.

[15]  K. Curtis,et al.  Laboratory and Field Evaluation of a New Rapid Test for Detecting Wuchereria bancrofti Antigen in Human Blood , 2013, The American journal of tropical medicine and hygiene.

[16]  Global programme to eliminate lymphatic filariasis: progress report, 2011. , 2012, Releve epidemiologique hebdomadaire.

[17]  Shannon K. McClintock,et al.  First evidence of spatial clustering of lymphatic filariasis in an Aedes polynesiensis endemic area. , 2011, Acta tropica.

[18]  Emily Zielinski-Gutierrez,et al.  Improving community participation to eliminate lymphatic filariasis in American Samoa. , 2011, Acta tropica.

[19]  P. J. Hooper,et al.  The Economic Benefits Resulting from the First 8 Years of the Global Programme to Eliminate Lymphatic Filariasis (2000–2007) , 2010, PLoS neglected tropical diseases.

[20]  Shannon K. McClintock,et al.  A Community-Based Study of Factors Associated with Continuing Transmission of Lymphatic Filariasis in Leogane, Haiti , 2010, PLoS neglected tropical diseases.

[21]  T. Handzel,et al.  Impact of five annual rounds of mass drug administration with diethylcarbamazine and albendazole on Wuchereria bancrofti infection in American Samoa. , 2008, The American journal of tropical medicine and hygiene.

[22]  E. Ottesen,et al.  Lymphatic filariasis: an infection of childhood , 2001, Tropical medicine & international health : TM & IH.

[23]  J B Carlin,et al.  Design of cross‐sectional surveys using cluster sampling: an overview with Australian case studies , 1999, Australian and New Zealand journal of public health.

[24]  S. Chanteau,et al.  Periodicity of Wuchereria bancrofti var. pacifica filariasis in French Polynesia. , 1993, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[25]  L. Brabin Sex differentials in susceptibility to lymphatic filariasis and implications for maternal child immunity , 1990, Epidemiology and Infection.

[26]  S. Ramalingam The epidemiology of filarial transmission in Samoa and Tonga. , 1968, Annals of tropical medicine and parasitology.